How to manage aspergillosis in non-neutropenic intensive care unit patients

Matteo Bassetti, Elda Righi, Gennaro De Pascale, Raffaele De Gaudio, Antonino Giarratano, Tereesita Mazzei, Giulia Morace, Nicola Petrosillo, Stefania Stefani, Massimo Antonelli

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Invasive aspergillosis has been mainly reported among immunocompromised patients during prolonged periods of neutropenia. Recently, however, non-neutropenic patients in the ICU population have shown an increasing risk profile for aspergillosis. Associations with chronic obstructive pulmonary disease and corticosteroid therapy have been frequently documented in this cohort. Difficulties in achieving a timely diagnosis of aspergillosis in non-neutropenic patients is related to the non-specificity of symptoms and to lower yields with microbiological tests compared to neutropenic patients. Since high mortality rates are typical of invasive aspergillosis in critically ill patients, a high level of suspicion and prompt initiation of adequate antifungal treatment are mandatory. Epidemiology, risk factors, diagnostic algorithms, and different approaches in antifungal therapy for invasive aspergillosis in non-neutropenic patients are reviewed.

Original languageEnglish
Article number458
JournalCritical Care
Volume18
Issue number4
DOIs
Publication statusPublished - Jul 25 2014

Fingerprint

Aspergillosis
Intensive Care Units
Immunocompromised Host
Neutropenia
Critical Illness
Chronic Obstructive Pulmonary Disease
Adrenal Cortex Hormones
Epidemiology
Therapeutics
Mortality
Population

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Medicine(all)

Cite this

Bassetti, M., Righi, E., De Pascale, G., De Gaudio, R., Giarratano, A., Mazzei, T., ... Antonelli, M. (2014). How to manage aspergillosis in non-neutropenic intensive care unit patients. Critical Care, 18(4), [458]. https://doi.org/10.1186/s13054-014-0458-4

How to manage aspergillosis in non-neutropenic intensive care unit patients. / Bassetti, Matteo; Righi, Elda; De Pascale, Gennaro; De Gaudio, Raffaele; Giarratano, Antonino; Mazzei, Tereesita; Morace, Giulia; Petrosillo, Nicola; Stefani, Stefania; Antonelli, Massimo.

In: Critical Care, Vol. 18, No. 4, 458, 25.07.2014.

Research output: Contribution to journalArticle

Bassetti, M, Righi, E, De Pascale, G, De Gaudio, R, Giarratano, A, Mazzei, T, Morace, G, Petrosillo, N, Stefani, S & Antonelli, M 2014, 'How to manage aspergillosis in non-neutropenic intensive care unit patients', Critical Care, vol. 18, no. 4, 458. https://doi.org/10.1186/s13054-014-0458-4
Bassetti M, Righi E, De Pascale G, De Gaudio R, Giarratano A, Mazzei T et al. How to manage aspergillosis in non-neutropenic intensive care unit patients. Critical Care. 2014 Jul 25;18(4). 458. https://doi.org/10.1186/s13054-014-0458-4
Bassetti, Matteo ; Righi, Elda ; De Pascale, Gennaro ; De Gaudio, Raffaele ; Giarratano, Antonino ; Mazzei, Tereesita ; Morace, Giulia ; Petrosillo, Nicola ; Stefani, Stefania ; Antonelli, Massimo. / How to manage aspergillosis in non-neutropenic intensive care unit patients. In: Critical Care. 2014 ; Vol. 18, No. 4.
@article{a2686659eedc42e1bddc6f753c20bcb3,
title = "How to manage aspergillosis in non-neutropenic intensive care unit patients",
abstract = "Invasive aspergillosis has been mainly reported among immunocompromised patients during prolonged periods of neutropenia. Recently, however, non-neutropenic patients in the ICU population have shown an increasing risk profile for aspergillosis. Associations with chronic obstructive pulmonary disease and corticosteroid therapy have been frequently documented in this cohort. Difficulties in achieving a timely diagnosis of aspergillosis in non-neutropenic patients is related to the non-specificity of symptoms and to lower yields with microbiological tests compared to neutropenic patients. Since high mortality rates are typical of invasive aspergillosis in critically ill patients, a high level of suspicion and prompt initiation of adequate antifungal treatment are mandatory. Epidemiology, risk factors, diagnostic algorithms, and different approaches in antifungal therapy for invasive aspergillosis in non-neutropenic patients are reviewed.",
author = "Matteo Bassetti and Elda Righi and {De Pascale}, Gennaro and {De Gaudio}, Raffaele and Antonino Giarratano and Tereesita Mazzei and Giulia Morace and Nicola Petrosillo and Stefania Stefani and Massimo Antonelli",
year = "2014",
month = "7",
day = "25",
doi = "10.1186/s13054-014-0458-4",
language = "English",
volume = "18",
journal = "Critical Care",
issn = "1466-609X",
publisher = "Springer Science + Business Media",
number = "4",

}

TY - JOUR

T1 - How to manage aspergillosis in non-neutropenic intensive care unit patients

AU - Bassetti, Matteo

AU - Righi, Elda

AU - De Pascale, Gennaro

AU - De Gaudio, Raffaele

AU - Giarratano, Antonino

AU - Mazzei, Tereesita

AU - Morace, Giulia

AU - Petrosillo, Nicola

AU - Stefani, Stefania

AU - Antonelli, Massimo

PY - 2014/7/25

Y1 - 2014/7/25

N2 - Invasive aspergillosis has been mainly reported among immunocompromised patients during prolonged periods of neutropenia. Recently, however, non-neutropenic patients in the ICU population have shown an increasing risk profile for aspergillosis. Associations with chronic obstructive pulmonary disease and corticosteroid therapy have been frequently documented in this cohort. Difficulties in achieving a timely diagnosis of aspergillosis in non-neutropenic patients is related to the non-specificity of symptoms and to lower yields with microbiological tests compared to neutropenic patients. Since high mortality rates are typical of invasive aspergillosis in critically ill patients, a high level of suspicion and prompt initiation of adequate antifungal treatment are mandatory. Epidemiology, risk factors, diagnostic algorithms, and different approaches in antifungal therapy for invasive aspergillosis in non-neutropenic patients are reviewed.

AB - Invasive aspergillosis has been mainly reported among immunocompromised patients during prolonged periods of neutropenia. Recently, however, non-neutropenic patients in the ICU population have shown an increasing risk profile for aspergillosis. Associations with chronic obstructive pulmonary disease and corticosteroid therapy have been frequently documented in this cohort. Difficulties in achieving a timely diagnosis of aspergillosis in non-neutropenic patients is related to the non-specificity of symptoms and to lower yields with microbiological tests compared to neutropenic patients. Since high mortality rates are typical of invasive aspergillosis in critically ill patients, a high level of suspicion and prompt initiation of adequate antifungal treatment are mandatory. Epidemiology, risk factors, diagnostic algorithms, and different approaches in antifungal therapy for invasive aspergillosis in non-neutropenic patients are reviewed.

UR - http://www.scopus.com/inward/record.url?scp=84928490171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928490171&partnerID=8YFLogxK

U2 - 10.1186/s13054-014-0458-4

DO - 10.1186/s13054-014-0458-4

M3 - Article

C2 - 25167934

AN - SCOPUS:84928490171

VL - 18

JO - Critical Care

JF - Critical Care

SN - 1466-609X

IS - 4

M1 - 458

ER -